Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Next, GS-4997, a specific ASK1 inhibitor, was used to confirm that the expression of SREBF1 and PLIN2 is regulated by ASK1-p38/JNK signalling
Recent animal- and human-based studies described the enhanced percentage of eryptotic erythrocytes in patients with hepatic failure and hyperbilirubinemia [210, 250, 280, 283, 284]
Both were placed on FDA Category 2 in September 2023, removed in September 2024 after withdrawn nominations, and reviewed by PCAC in late 2024 with FDA recommending against 503A Bulks inclusion
PMCID: PMC6518405
US$ 21.24
US$ 24.38
US$ 22.06
US$ 21.39
US$ 20.00
US$ 21.54
US$ 26.88
